Unique ID issued by UMIN | UMIN000007086 |
---|---|
Receipt number | R000008258 |
Scientific Title | An observational study For Investigating success in achieving clinical, structual and functional Remission and Sustaining efficacy with Tocilizumab |
Date of disclosure of the study information | 2012/01/17 |
Last modified on | 2021/01/25 16:40:37 |
An observational study For Investigating success in achieving clinical, structual and functional Remission and Sustaining efficacy with Tocilizumab
ACTemra Investigation for remission introduction and VITality of remission . retrospective studY
An observational study For Investigating success in achieving clinical, structual and functional Remission and Sustaining efficacy with Tocilizumab
ACTemra Investigation for remission introduction and VITality of remission . retrospective studY
Japan |
Rheumatoid Arthritis
Medicine in general | Endocrinology and Metabolism | Clinical immunology |
Others
NO
Investigation of achievement of clinical, structural and functional remission and the possibility of maintenance with tocilizumab in daily clinical practice.
Efficacy
Confirmatory
Pragmatic
Not applicable
Percentages of three different remissions; clinical remission (the disease activity score using the 28 joint count [DAS28]-ESR), structural remission (modified total Sharp score [mTSS]), and functional remission (health assessment questionnaire [HAQ] at week 104 after tocilizumab treatment.
Maintenance period of clinical , structual and functional remission
Observational
18 | years-old | <= |
Not applicable |
Male and Female
1)RA patients who fulfilled the ACR classification criteria.
2) Rheumatoid arthritis diagnosed by ACR/EULAR new classification criteria for RA
No criteria
200
1st name | Yoshiya |
Middle name | |
Last name | Tanaka |
University of Occupational and Environmental Health, Japan
The First Department of Internal Medicine, School of Medicine
8078555
1-1, Iseigaoka, Yahatanishi, Kitakyushu, Japan
0936031611
hanami@med.uoeh-u.ac.jp
1st name | kentaro |
Middle name | |
Last name | hanami |
University of Occupational and Environmental Health, Japan
The First Department of Internal Medicine, School of Medicine
8078555
1-1, Iseigaoka, Yahatanishi, Kitakyushu, Japan
093-603-1611
hanami@med.uoeh-u.ac.jp
University of Occupational and Environmental Health, Japan
University of Occupational and Environmental Health, Japan
Self funding
University of Occupational and Environmental Health, Japan
1-1, Iseigaoka, Yahatanishi, Kitakyushu, Japan
093-603-1611
daigakukanri@mbox.pub.uoeh-u.ac.jp
NO
2012 | Year | 01 | Month | 17 | Day |
Unpublished
710
No longer recruiting
2008 | Year | 04 | Month | 01 | Day |
2008 | Year | 08 | Month | 12 | Day |
2008 | Year | 04 | Month | 01 | Day |
2023 | Year | 03 | Month | 31 | Day |
Percentages of three different remissions; clinical remission (DAS28-ESR<2.6), structural remission (mTSS<0.5), and functional remission (HAQ<0.5) at week 104 after tocilizumab treatment.
2012 | Year | 01 | Month | 17 | Day |
2021 | Year | 01 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008258
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |